We then assessed the relationship between B7-H3 expression and survival, and found that B7-H3 expression was significantly associated with poorer 5-year breast cancer specific survival (BCSS) in the unselected breast cancer cohort (Figure 2f, p = 0.0011, log rank). Here, CD276 is linked to breast cancer.